Drospirenone: pharmacology and pharmacokinetics of a unique progestogen
about
Combined oral contraceptives: the risk of myocardial infarction and ischemic strokeCombined oral contraceptives: the risk of myocardial infarction and ischemic strokeTypes of progestogens in combined oral contraception: effectiveness and side-effectsEuropean active surveillance study of women taking HRT (EURAS-HRT): study protocol [NCT00214903].The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells.Pharmacology of estrogens and progestogens: influence of different routes of administrationDrospirenone and its antialdosterone propertiesInternational Active Surveillance Study of Women Taking Oral Contraceptives (INAS-OC Study).A combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilation.Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorderProgestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effectsNew progestagens for contraceptive use.Hormonal therapies in acne.Oxidant/antioxidant status, paraoxonase activity, and lipid profile in plasma of ovariectomized rats under the influence of estrogen, estrogen combined with progesterone, and genistein.Cardiovascular disease and primary ovarian insufficiency.Drospirenone plus estradiol and the risk of serious cardiovascular events in postmenopausal women.Role of progestins with partial antiandrogenic effects.Combined oral contraceptives in the treatment of polycystic ovary syndrome.Fourth-Generation Progestins Inhibit 3β-Hydroxysteroid Dehydrogenase Type 2 and Modulate the Biosynthesis of Endogenous Steroids.Pharmacokinetics of drospirenone and ethinylestradiol in Caucasian and Japanese women.Pharmacology of different progestogens: the special case of drospirenone.Effects of drospirenone/estrogen combinations on bone metabolism.A comparative efficacy of low-dose combined oral contraceptives containing desogestrel and drospirenone in premenstrual symptoms.Drospirenone and estradiol: a new option for the postmenopausal woman.Drospirenone with 17beta-estradiol in the postmenopausal woman with hypertension.Effects of blood pressure reduction on cardiovascular risk estimates in hypertensive postmenopausal women.Drospirenone: a novel progestin.Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists.Advances in hormone replacement therapy: weight benefits of drospirenone, a 17alpha-spirolactone-derived progestogen.Contraceptive hormone use and cardiovascular diseaseEffects of drospirenone pill in Indian women with polycystic ovary syndrome.Efficacy and safety of drospirenone 2 mg/17β-estradiol 1 mg hormone therapy in Korean postmenopausal women.Update on newer antihypertensive medicines and interventions.Drospirenone/ethinylestradiol: a review on efficacy and noncontraceptive benefits.The combined oral contraceptive pill containing drospirenone and ethinyl estradiol plus levomefolate calcium.Contraceptives with novel benefits.Beyaz®: an oral contraceptive fortified with folate.Comprehensive evaluation of Safyral(®) 2012.Targeting the mineralocorticoid receptor in cardiovascular disease.Pharmaceuticals and personal care products: A critical review of the impacts on fish reproduction.
P2860
Q24187746-1B951863-9CD1-44A1-B495-3FA50AF884A0Q24198194-C319B431-D038-47A4-8750-03BB4F070981Q24234457-5C8CF805-CEC9-44E5-A49E-6CC9158AC607Q25255687-A61FCBAA-6D01-49CA-B88D-6640BA4D20C5Q25257485-D9F86F43-385F-45FE-88F6-8D04DBA115ECQ28268346-FCDDFBFA-22C7-4467-B0A0-C7A379B83A7EQ28293272-7CDECF98-7D5E-495E-B4D4-AE8ED53386C3Q30891586-1FB0D0CA-0737-43F3-AD3C-C79EB239823DQ34145361-F2281B0B-C061-4F44-B477-B44637BCC771Q34272049-1F935FA8-162C-4FE0-B4C6-9061B3F48123Q34317537-E4DDE5CB-D7E7-488B-947E-F7E1C7B89B4AQ34468158-89D21412-D809-4731-AF1F-70C0318FA4CEQ34706886-DB7D4587-46CA-4BE8-AC02-D801A85F5164Q35746794-7F6BB792-787C-41C8-9C8E-EF5FD73D616EQ35965092-3E636419-CD6C-47E7-BA67-C79569DED368Q36016412-08F9A9D3-1CF4-479F-911E-4772BF05DB7DQ36019567-DE578680-6438-4111-AA78-1D663176E6E8Q36080057-C72E1BCF-08BB-4E7E-82CF-1603B3280F69Q36153866-B8737615-B7C9-424D-8E74-A356CB8CC8B8Q36228149-FA1C3728-1D52-4231-B38A-626D8E268A78Q36276322-7289AB3D-756F-4748-8A16-B9D6E3EF85E1Q36276339-463DC052-2CBA-4242-98B4-D95DD6F9D899Q36720116-99089661-4CD4-4555-8143-EC34495AB78FQ36761429-EBFB3889-4FE6-4096-80E0-CEFC0BD19ACFQ36761438-628A7375-6C55-4556-9894-05A2E236D94AQ36761442-A2593E61-FBDE-4789-BFC5-884D64BFF2E7Q36808051-DE0991A5-D2BA-4B6E-A91C-8C979225B5AEQ37020195-23EF46CE-82D0-4BC9-BC0F-1A43F4DF49CCQ37030687-DBC78BA5-23EF-486E-B5FA-5BF845016866Q37138852-FEC20335-31B3-4FA1-B61E-3A116D649886Q37611368-BEC5AE4A-B51E-49F3-8E0C-E280F905C072Q37718913-E44E3182-2E95-4F70-8608-3CFFC7A51603Q37753547-4744A65F-4A3B-4E48-B287-AE2774CC5DA4Q37822793-7C2195D9-E674-4FD5-8439-D03E0CB1E9D6Q37923956-5CB5261A-3703-47D7-A66B-DAC6D55A8C2EQ37965736-B6C6A2F3-7760-48C7-A156-87F768F1CF5FQ37968645-FC69F735-4258-4AF9-A56C-FB850DB07F5BQ38062561-A33ED128-C973-44F8-B496-5176352443D1Q38074488-8CF6BDC7-D3DF-4F9C-9758-52B5F46AF950Q38461963-D0F72CD0-651A-4A15-91AC-A59CA425741C
P2860
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen
@ast
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen
@en
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen
@nl
type
label
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen
@ast
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen
@en
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen
@nl
prefLabel
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen
@ast
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen
@en
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen
@nl
P3181
P1433
P1476
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen
@en
P2093
R Krattenmacher
P3181
P356
10.1016/S0010-7824(00)00133-5
P407
P577
2000-07-01T00:00:00Z